Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.
Swarm Oncology has raised $8.1M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Swarm Oncology's investors include Delin Ventures.
Swarm Oncology is headquartered in London, United Kingdom.
Swarm Oncology is a biotechnology company that develops novel T cell therapies for cancer patients.
Swarm Oncology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Swarm Oncology — Funding & Investors." VCBacked, March 5, 2026, https://www.vcbacked.co/company/swarm-oncology. Accessed September 30, 2026.
VCBacked. (2026). Swarm Oncology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/swarm-oncology
{{cite web |title=Swarm Oncology — Funding & Investors |url=https://www.vcbacked.co/company/swarm-oncology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated